(Press-News.org) Research with human tissue and cells suggests that genetic variations, in addition to failure to comply with treatment regimens, may account for some failures of an anti-HIV drug to treat and prevent HIV infection.
In a report described online today in the journal EBioMedicine, investigators at Johns Hopkins found that tenofovir, marketed as Viread, is processed differently according to cell location, so that if the drug is eventually marketed as a topical gel, it could work differently depending on whether it is applied to the vagina or the rectum.
Tenofovir has been approved since 2001 by the U.S. Food and Drug Administration to treat HIV. It is also a component of Truvada, a drug that was approved in 2012 as an oral prophylactic for use in preventing HIV infection.
"If confirmed by further studies, our results suggest that in the future, before prescribing tenofovir to a patient, a doctor could order genetic testing and know in advance if it works, and prescribe a different drug if it won't," says Namandje Bumpus, Ph.D. , associate professor of medicine at the Johns Hopkins University School of Medicine.
Bumpus and her colleagues focused their research on a search for the human enzymes that convert tenofovir from its original form to an activated one that combats HIV. Previous studies had revealed that the key to such activation is the addition of two molecules known as phosphate groups, she says.
Working with blood and tissue from healthy research subjects, her team "knocked out" genes for phosphate-adding enzymes one by one, then exposed the tissues' cells to tenofovir to test whether they were able to activate the drug.
To their surprise, says Bumpus, they learned that the enzyme that added the second phosphate to activate the drug in the blood and vaginal tissues, pyruvate kinase, was different from that which performed the second activation step in the colorectal tissues, known as creatine kinase.
In further experiments, the research team sequenced the genes of 142 women who had participated in a clinical trial of tenofovir to look for genetic variations that might have affected the function of pyruvate kinase, creatine kinase or the enzyme that performed the first activation step in all of the cells, adenylate kinase 2. They found 71 such variants, several of which a computer model predicted would make the enzyme ineffective. In all, 8 percent of the women had genetic variants that were likely to make them unable to convert tenofovir to its activated form.
"Tenofovir has been shown in trials to be very effective, so when it doesn't work, researchers and clinicians tend to assume the individual just wasn't taking the drug as directed," Bumpus says. "That is probably true in most cases, but in others, it's possible that genetic variation is actually at fault."
The team's next step, Bumpus says, will be to design a clinical trial to confirm the association between specific variants and how well the drug works.
INFORMATION:
Other authors on the paper are Julie M. Lade, Elaine E. To and Craig W. Hendrix, all of the Johns Hopkins University School of Medicine.
The study was funded by the National Institute of Allergy and Infectious Diseases (grant numbers UM1AI068633, UM1AI068615, UM1AI106707, UM1AI068613 and P30 AI094189), the Johns Hopkins University Center for AIDS Research, and the National Institute of General Medical Sciences (grant number R01 GM103853).
This news release is available in French. Montreal, July 9, 2015 -- Death rates due to health problems like obesity, type 2 diabetes, hypertension, and heart disease are on the rise. According to the World Health Organization, that's due to our increasingly sedentary lifestyles.
Clearly, it's important to lead more active lives. Something as simple as taking the stairs can make a big difference. But can pedestrians be convinced to make healthy choices when an escalator seems so much faster and more convenient than a staircase?
Yes, say researchers from Concordia ...
Around 85% of the matter in the Universe is dark [1], and of a type not understood by physicists. Although it doesn't shine or absorb light, astronomers can detect this dark matter through its effect on stars and galaxies, specifically from its gravitational pull. A major project using ESO's powerful survey telescopes is now showing more clearly than ever before the relationships between this mysterious dark matter and the shining galaxies that we can observe directly [2].
The project, known as the Kilo-Degree Survey (KiDS - http://kids.strw.leidenuniv.nl/), uses imaging ...
Childhood high blood pressure (HBP) is a serious public health challenge worldwide due to associated increases in risk of end organ damages and correlation with HBP in adulthood. The prevalence of elevated blood pressure (BP) has been reported to increase significantly among United States children and adolescents from 1988-1994 to 1999-2008, but little is known about recent trends in BP values and elevated BP. The authors of a new study, "Trends in elevated blood pressure among US children and adolescents: 1999-2012," published today by the American Journal of Hypertension, ...
ANN ARBOR--University of Michigan researchers and their colleagues predict that the 2015 western Lake Erie harmful algal bloom season will be among the most severe in recent years and could become the second-most severe behind the record-setting 2011 bloom.
The 2015 seasonal forecast uses models that translate spring nutrient loading into predicted algal blooms in the Western Basin of Lake Erie. After a relatively dry April and May, the heavy rains in June produced record discharge and nutrient loadings from the Maumee River, which runs through Toledo and northeastern ...
This news release is available in German.
Graphene, the only one atom thick carbon network, achieved overnight fame with the 2010 Nobel Prize. But now comes competition: Such layers can also be formed by black phosphorous. Chemists at the Technische Universität München (TUM) have now developed a semiconducting material in which individual phosphorus atoms are replaced by arsenic. In a collaborative international effort, American colleagues have built the first field-effect transistors from the new material.
For many decades silicon has formed the ...
Chicago - Although opioids are frequently prescribed to treat chronic lower back pain, new research suggests these powerful medications may be less effective in some patients. A study published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists® (ASA®), found patients who were prescribed opioids to treat chronic lower back pain experienced significantly less pain relief and were more likely to abuse their medication when they had psychiatric disorders such as depression or anxiety.
"High levels ...
Neuroscientists at Duke University have introduced a new paradigm for brain-machine interfaces that investigates the physiological properties and adaptability of brain circuits, and how the brains of two or more animals can work together to complete simple tasks.
These brain networks, or Brainets, are described in two articles to be published in the July 9, 2015, issue of Scientific Reports. In separate experiments reported in the journal, the brains of monkeys and the brains of rats are linked, allowing the animals to exchange sensory and motor information in real time ...
The human eye is an amazing instrument and can accurately distinguish between the tiniest, most subtle differences in color. Where human vision excels in one area, it seems to fall short in others, such as perceiving minuscule details because of the natural limitations of human optics.
In a paper published today in The Optical Society's new, high-impact journal Optica, a research team from the University of Stuttgart, Germany and the University of Eastern Finland, Joensuu, Finland, has harnessed the human eye's color-sensing strengths to give the eye the ability to ...
UBC research shows world's monitored seabird populations have dropped 70 per cent since the 1950s, a stark indication that marine ecosystems are not doing well.
Michelle Paleczny, a UBC master's student and researcher with the Sea Around Us project, and co-authors compiled information on more than 500 seabird populations from around the world, representing 19 per cent of the global seabird population. They found overall populations had declined by 69.6 per cent, equivalent to a loss of about 230 million birds in 60 years.
"Seabirds are particularly good indicators of ...
Chemotherapy treatment usually involves the patient receiving medicine through an intravenous catheter. These catheters, as well as the the equipment attached to them, are treated with a silver coating which is antibacterial, preventing bacterial growth and unwanted infections during a treatment.
Researchers at the Norwegian University of Science and Technology's (NTNU) Department of Physics are now studying what happens when different drugs come in contact with this silver coating.
Silver breaks down chemotherapy drugs
"We wanted to find potential problem sources ...
